Border to Coast Pensions Partnership Ltd Has $82.35 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Border to Coast Pensions Partnership Ltd boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 141,265 shares of the healthcare conglomerate’s stock after purchasing an additional 6,026 shares during the quarter. UnitedHealth Group accounts for approximately 1.7% of Border to Coast Pensions Partnership Ltd’s holdings, making the stock its 13th biggest position. Border to Coast Pensions Partnership Ltd’s holdings in UnitedHealth Group were worth $82,354,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Swedbank AB bought a new stake in shares of UnitedHealth Group in the 1st quarter worth about $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in UnitedHealth Group by 107.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after purchasing an additional 1,196,758 shares during the period. Lone Pine Capital LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at about $480,903,000. Dimensional Fund Advisors LP raised its position in shares of UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the period. Finally, Baillie Gifford & Co. raised its position in shares of UnitedHealth Group by 1,125.4% in the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after acquiring an additional 821,050 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.8 %

Shares of UNH stock traded up $4.56 during midday trading on Monday, reaching $574.17. 1,640,859 shares of the stock were exchanged, compared to its average volume of 3,955,033. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The company’s 50 day moving average is $584.42 and its two-hundred day moving average is $534.68. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The firm has a market cap of $530.20 billion, a PE ratio of 37.11, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $6.56 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on UNH. Bank of America cut their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. TD Cowen raised their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday, October 16th. Argus raised their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Truist Financial reaffirmed a “buy” rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $615.58.

Get Our Latest Research Report on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).